Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W B Knight

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Journal of Medicinal Chemistry|September 1, 1990
Inhibition of human leukocyte elastase. 2. Inhibition by substituted cephalosporin esters and amidesP E Finke, B M Ashe, W B Knight, et al.
Biochemistry|September 8, 1992
Specificity, stability, and potency of monocyclic beta-lactam inhibitors of human leucocyte elastaseW B Knight, B G Green, R M Chabin, et al.
Journal of Medicinal Chemistry|March 19, 1993
Orally active beta-lactam inhibitors of human leukocyte elastase. 2. Effect of C-4 substitutionW K Hagmann, A L Kissinger, S K Shah, et al.
Molecular Cancer Therapeutics|December 7, 2002
The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivoD W Rusnak, K Lackey, K Affleck, et al.
Connective Tissue Research|January 1, 1996
Proteoglycan-degrading activity of human stromelysin-1 and leukocyte elastase in rabbit joints. Quantitation of proteoglycan and a stromelysin-induced HABR fragment of aggrecan in synovial fluid and cartilageJ M Olszewski, V L Moore, J McDonnell, et al.
Cancer Research|October 5, 2001
The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancerD W Rusnak, K Affleck, S G Cockerill, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Journal of Medicinal Chemistry|September 1, 1990
Inhibition of human leukocyte elastase. 2. Inhibition by substituted cephalosporin esters and amidesP E Finke, B M Ashe, W B Knight, et al.
Biochemistry|September 8, 1992
Specificity, stability, and potency of monocyclic beta-lactam inhibitors of human leucocyte elastaseW B Knight, B G Green, R M Chabin, et al.
Journal of Medicinal Chemistry|March 19, 1993
Orally active beta-lactam inhibitors of human leukocyte elastase. 2. Effect of C-4 substitutionW K Hagmann, A L Kissinger, S K Shah, et al.
Molecular Cancer Therapeutics|December 7, 2002
The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivoD W Rusnak, K Lackey, K Affleck, et al.
Connective Tissue Research|January 1, 1996
Proteoglycan-degrading activity of human stromelysin-1 and leukocyte elastase in rabbit joints. Quantitation of proteoglycan and a stromelysin-induced HABR fragment of aggrecan in synovial fluid and cartilageJ M Olszewski, V L Moore, J McDonnell, et al.
Cancer Research|October 5, 2001
The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancerD W Rusnak, K Affleck, S G Cockerill, et al.
Pageof 6